Buyers of designer babies will be overwhelmed by choice
by Michael Cook | 8 Sep 2018 | 1 comment
The dream of “designer babies” is probably further off than most of us think because of all the technical issues involved. But it is coming down the pike. In the latest issue of the Journal of Law and the Biosciences Sonia M. Suter, of George Washington University, speculates about how a designer baby market would actually work.
In the first place, it would require industrial-scale preimplantation genetic diagnosis (PGD) and genome sequencing. Both are already available, although there is room for much improvement. The missing link is in vitro gametogenesis – creating sperm and eggs from somatic cells. So far this technology has been unsuccessful in humans, but it is possible to envisage a situation in a woman using IVG could produce 10,000 eggs, and thus 10,000 embryos. As an author referenced in Suter’s paper points out, “If IVG could be used to create 10,000 embryos for IVF, then this could improve the chances of finding the preferred genotype from just over 1% to more than 99.99%.” This is what Suter calls Easy PGD, or EPGD. She doesn’t explain what will happen to the other 9,999 embryos.
The point of Suter’s paper is that consumers could become paralyzed by the abundance of choice in choosing their offspring. Parents will be confronted with “dizzying amounts of probabilistic information about an enormous range of health risks and traits for each embryo. Making sense of that for one embryo is challenging enough; trying to make sense of it for tens or hundreds of embryos would be even more daunting.” They would require expert assistance to achieve their unique (or not so unique) combination of ideal baby likes and dislikes, from geneticists or from computer algorithms.
Suter points out that this might change “the reproductive experience”:
... the ability to select among so many embryos based on non-medical traits and less serious diseases could gradually, but profoundly, alter attitudes about what is in the future child's best interest. More important, it could shift the goal of selection from preventing harm to ‘perfecting’ reproduction far more than occurs today with prenatal testing. These cultural shifts would routinize selection against not just disabilities, but also disfavored non-medical traits, ultimately leading to a vicious cycle: reproductive choices would reinforce prejudice by reducing the number of children born with the disfavored disabilities or traits, which would increase selection against those traits, thereby further reinforcing prejudice, etc. While such a vicious cycle already exists with current reproductive technologies, the degree would be significantly different with EPGD, potentially changing the experience in kind.
Similar challenges to choice already exist, thanks to the internet, like selecting a partner or a sperm donor.
... one can easily envision fertility clinics offering different selection methods for EPGD along the lines of these different types of dating or sperm bank websites. Instead of eHarmony, imagine EmbryoHarmony,153 and instead of DonorMatchMe, imagine BabyMatch. If EPGD becomes an accepted form of ART, rather than leave parents to wade unassisted through the thicket of so much information, clinics would likely offer a range of algorithms to ease decision making. One can visualize the advertisements touting their potential to optimize the ability to find the ‘ideal’ parent–child match or to have children with a greater chance of health, ‘success,’ or well-being.
Sunday, September 9, 2018
John Robertson was an American scholar in law and bioethics who died last year. He is best known for making a strong case for “procreative liberty”, whether procreation takes place naturally or with the help of technology. As a tribute to his influence, the current issue of the Journal of Law and the Biosciences contains several articles about this theory.
Robertson’s theme was that reproductive choices which do not harm the interests of others should not be subject to regulation or prohibition. In his best-known book, Children of Choice, published in 1996, he discussed abortion, IVF, surrogacy and pre-natal genetic modification. But time has moved on. The principle of effectively unconstrained “procreative liberty” is being used to justify other developments, some of which are discussed in the Journal, including unisex gestation.
What I found interesting was that Robertson, in a paper written not long before his death, agreed that a male pregnancy (after a womb transplant) could be ethically justified, but only if it were necessary for genetic reproduction. Even he wanted to draw a line somewhere.
However, the author of one of tribute essays questions this restriction. Enjoying the experience of gestation is reason enough, she says. (See below). I suppose that this raises the question of whether it is possible to draw any lines, anywhere, once we agree that reproductive rights should not be limited.
Robertson’s theme was that reproductive choices which do not harm the interests of others should not be subject to regulation or prohibition. In his best-known book, Children of Choice, published in 1996, he discussed abortion, IVF, surrogacy and pre-natal genetic modification. But time has moved on. The principle of effectively unconstrained “procreative liberty” is being used to justify other developments, some of which are discussed in the Journal, including unisex gestation.
What I found interesting was that Robertson, in a paper written not long before his death, agreed that a male pregnancy (after a womb transplant) could be ethically justified, but only if it were necessary for genetic reproduction. Even he wanted to draw a line somewhere.
However, the author of one of tribute essays questions this restriction. Enjoying the experience of gestation is reason enough, she says. (See below). I suppose that this raises the question of whether it is possible to draw any lines, anywhere, once we agree that reproductive rights should not be limited.
Michael Cook Editor BioEdge |
NEWS THIS WEEK
by Michael Cook | Sep 08, 2018
Supporters want to extend its funding by Michael Cook | Sep 08, 2018
With womb transplants on the way, we have to ask the question by Xavier Symons | Sep 08, 2018
A pregnant Jehovah's Witness teenager had refused the procedureby Xavier Symons | Sep 08, 2018
Diabetics are rationing insulin injections. by Xavier Symons | Sep 08, 2018
Doctors at the Moscow clinic cooperated with the woman's request. by Michael Cook | Sep 08, 2018
How does one choose amongst 10,000 options? by Michael Cook | Sep 08, 2018
Nearly 40 people have died in 2018 by Michael Cook | Sep 08, 2018
Larger studies are needed to confirm results by Michael Cook | Sep 08, 2018
Mohammed al-Bardan explains to the New York Times why he cares for patients in a rebel-held district of Syria BioEdge
Suite 12A, Level 2 | 5 George St | North Strathfield NSW 2137 | Australia
Phone: +61 2 8005 8605
Mobile: 0422-691-615
No hay comentarios:
Publicar un comentario